Pontos EULAR a considerar para o monitoramento de terapia medicamentosa com biofarmacêuticos em doenças inflamatórias reumáticas e musculoesqueléticas.

EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases – Annals of Rheumatic Diseases

Comentário no Twitter

Our 2022 EULAR points to consider on Therapeutic drug monitoring of biologics just published in @ARD_BMJ

A real pleasure being part of this steering group & collaborative taskforce expertly led by @ProfJohnIsaacs

Clear points for practice& research👇https://t.co/YesEjajaIK pic.twitter.com/cQw8o1bjUw

— Meghna Jani (@MeghnaJani) May 15, 2022